Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,787 signal articles · 255 in last 24h · 118,124 total before filter · latest 56m ago
255last 24h
1591last 7d
250● bullish (7d)
160● bearish (7d)
205publishers
AllMacro307Earnings651M&A92Regulatory28Product13Analyst24
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Investing.com11d agobullish
Citadel’s Rubner says it’s time to start buying gold again

Investing.com - Citadel Securities' Scott Rubner has started advocating for adding structural exposure to gold for the first time in 2026, calling the current precious metals setup "one of the more compelling upside setups we have seen in precious metals in months."

Atlassian earnings beat drives 30% stock surge
Proactive11d agobullish
Atlassian earnings beat drives 30% stock surge

Atlassian (NASDAQ:TEAM) shares jumped more than 30% on Friday after the software maker posted fourth-quarter revenue and cloud growth that topped analyst estimates and issued a stronger-than-expected cloud revenue outlook for fiscal 2027. Revenue for the quarter came in at $1.8 billion, up...

Bloomberg11d agobullish
Non-Opioid Painkiller Maker Latigo Jumps 17% After Upsized IPO

(Bloomberg) -- Latigo Biotherapeutics Inc., a clinical-stage developer of non-opioid pain medicines, climbed 17% on Friday after raising $345.6 million in an upsized initial public offering, priced at the top of a marketed range.Most Read from BloombergOpenAI’s New Device Will Be Hockey Puck-Sized and Cost Over $300Iran Wants to Bar US, Israeli Ships From Hormuz in Peace AccordIran Says Agreement on Hormuz Shipping Reached With OmanTrump Administration Considers Order on Autism and VaccinesWhy D